Effect of Boswellia serrata Extracts on Degenerative Osteoarthritis in vitro and in vivo Models

보스웰리아 추출물의 골관절염 억제 효과 연구

  • Received : 2014.03.31
  • Accepted : 2014.04.02
  • Published : 2014.05.31


The inhibitory effects of Boswellia serrata (BW) extracts on degenerative osteoarthritis were investigated in primary-cultured rat cartilage cells and a monosodium-iodoacetate (MIA)-induced osteoarthritis rat model. To identify the protective effects of BW extract against $H_2O_2$ ($800{\mu}M$, 2 hr) in vitro, cell survival was measured by MTT assay. Cell survival after $H_2O_2$ treatment was elevated by BW extract at a concentration of $20{\mu}g/mL$. In addition, BW extract treatment significantly reduced and normalized the productions of pro-inflammatory factors, nuclear transcription factor ${\kappa}B$, cyclooxygenase-2, tumor necrosis factor-${\alpha}$, and interleukin-6 at a concentration of $20{\mu}g/mL$. Treatment of chondrocytes with BW extract significantly reduced 5-lipoxygenase activity and production of prostaglandin E2, especially at a concentration of $10{\sim}20{\mu}g/mL$. For the in vivo animal study, osteoarthritis was induced by intra-articular injection of MIA into knee joints of rats. Consumption of a diet containing BW extract (100 and 200 mg/kg) for 35 days significantly inhibited the development and severity of osteoarthritis in rats. To determine the genetic expression of arthritic factors in articular cartilage, real-time PCR was applied to measure matrix metalloproteinases (MMP-3, MMP-9, and MMP-13), collagen type I, collagen type II, and aggrecan, and BW extract had protective effects at a concentration of 200 mg/kg. In conclusion, BW extract was able to inhibit articular cartilage degeneration by preventing extracellular matrix degradation and chondrocyte injury. One can consider that BW extract may be a potential therapeutic treatment for degenerative osteoarthritis.


  1. MOHW. 2012. Korea Health Statistics 2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3). Ministry of Health and Welfare, Sejong, Korea. p 67, 678.
  2. Garner BC, Stoker AM, Kuroki K, Evans R, Cook CR, Cook JL. 2011. Using animal models in osteoarthritis biomarker research. J Knee Surg 24: 251-264.
  3. Wu W, Xu X, Dai Y, Xia L. 2010. Therapeutic effect of the saponin fraction from Clematis chinensis Osbeck roots on osteoarthritis induced by monosodium iodoacetate through protecting articular cartilage. Phytother Res 24: 538-546.
  4. Wesche-Soldato DE, Swan RZ, Chung CS, Ayala A. 2007. The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets 8: 493-500.
  5. Herrington C, Hall PA. 2008. Molecular and cellular themes in inflammation and immunology. J Pathol 214: 123-125.
  6. Campo GM, Avenoso A, Campo S, D'Ascola A, Traina P, Sama D, Calatroni A. 2009. Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem 106: 83-92.
  7. Ammon HRT. 2010. Modulation of the immune system by Boswellia serrata extracts and boswellic acids. Phytomedicine 17: 862-867.
  8. Roy S, Khanna S, Krishnaraju AV, Subbaraju GV, Yasmin T, Bagchi D, Sen CK. 2006. Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory Boswellia. Antioxid Redox Sign 8: 653-660.
  9. Park B, Prasad S, Yadav V, Sung B, Aggarwal BB. 2011. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets. PLoS One 6: e26943.
  10. Sengupta K, Kolla JN, Krishnaraju AV, Yalamanchili N, Rao CV, Golakoti T, Raychaudhuri S, Raychaudhuri SP. 2011. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract. Mol Cell Biochem 354: 189-197.
  11. KHIDI. 2011. Health functional food industry development assistance report. Korea Health Industry Development Institute, Chungbuk, Korea. p 8.
  12. Lee JW, Do JH. 2005. Market trend of health functional food and the prospect of ginseng market. J Ginseng Res 29: 206-214.
  13. Kim HK. 2004. Current status and prospect of nutraceuticals. Food Industry and Nutrition 9(1): 1-14.
  14. Sailer ER, Subramanian LR, Rall B, Hoernlein RF, Ammon HP, Safayhi H. 1996. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activity. Br J Pharmacol 117: 615-618.
  15. Siddiqui MZ. 2011. Boswellia serrata, a potential antiinflammatory agent: an overview. Indian J Pharm Sci 73: 255-261.
  16. Ammon HP. 2006. Boswellic acids in chronic inflammatory diseases. Planta Med 72: 1100-1116.
  17. Khayyal MT, El-Ghazaly MA, El-Hazek RM, Nada AS. 2009. The effects of celecoxib, a COX-2 selective inhibitor, on acute inflammation induced in irradiated rats. Inflammopharmacology 17: 255-266.
  18. El-Ghazaly MA, Nada AS, El-Hazek RM, Khayyal MT. 2010. Effect of selective COX-2 inhibitor, celecoxib on adjuvant-induced arthritis model in irradiated rats. Int J Radiat Biol 86: 1079-1087.
  19. Mathy-Hartert M, Martin G, Devel P, Deby-Dupont G, Pujol JP, Reginster JY, Henrotin Y. 2003. Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes. Inflamm Res 52: 111-118.
  20. Asada S, Fukuda K, Oh M, Hamanishi C, Tanaka S. 1999. Effect of hydrogen peroxide on the metabolism of articular chondrocytes. Inflamm Res 48: 399-403.
  21. Khan IM, Gilbert SJ, Caterson B, Sandell LJ, Archer CW. 2008. Oxidative stress induces expression of osteoarthritis markers procollagen IIA and 3B3(-) in adult bovine articular cartilage. Osteoarthritis Cartilage 16: 698-707.
  22. Gilmore TD. 1999. The Rel/NF-kB signal transduction pathway: introducion. Oncogene 18: 6842-6844.
  23. Kim CS, Kawada T, Kim BS, Han IS, Choe SY, Kurata T, Yu R. 2003. Capsaicin exhibits anti-inflammatory property by inhibiting IkB-a degradation in LPS-stimulated peritoneal macrophages. Cell Signal 15: 299-306.
  24. Jotanovic Z, Mihelic R, Sestan B, Dembic Z. 2012. Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review. Drugs Aging 29: 343-358.
  25. Bauge C, Girard N, Leclercq S, Galera P, Boumediene K. 2012. Regulatory mechanism of transforming growth factor beta receptor type II degradation by interleukin-1 in primary chondrocytes. Biochim Biophys Acta-Mol Cell Res 1823: 983-986.
  26. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. 2011. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7: 33-42.
  27. Ghosh J, Myers CE. 1997. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun 235: 418-423.
  28. Sailer ER, Schweizer S, Boden SE, Ammon HP, Safayhi H. 1998. Characterization of an acetyl-11-keto-beta-boswellic acid and arachidonate-binding regulatory site of 5-lipoxygenase using photoaffinity labeling. Eur J Biochem 256: 364-368.
  29. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. 2000. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3'-untranslated region. J Biol Chem 275: 11750-11757.
  30. Newton R, Kuitert LM, Bergmann M, Adcock IM, Barnes PJ. 1997. Evidence for involvement of NF-${\kappa}$B in the transcriptional control of COX-2 gene expression by IL-1${\beta}$. Biochem Biophys Res Commun 237: 28-32.
  31. Vane JR, Bakhle YS, Botting RM. 1998. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120.
  32. Bensen WG, Fiechtner JJ, McMillen JI, Zhao WW, Yu SS, Woods EM, Hubbard RC, Isakson PC, Verburg KM, Geis GS. 1999. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial. Mayo Clin Proc 74: 1095-1105.
  33. Hardy MM, Seibert K, Manning PT, Currie MG, Woerner BM, Edwards D, Koki A, Tripp CS. 2002. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants. Arthritis Rheum 46: 1789-1803.
  34. Lee V, Cao L, Zhang Y, Kiani C, Adams ME, Yang BB. 2000. The roles of matrix molecules in mediating chondrocyte aggregation, attachment, and spreading. J Cell Biochem 79: 322-333.<322::AID-JCB150>3.0.CO;2-U
  35. Abaskharoun M, Bellemare M, Lau E, Margolis RU. 2010. Expression of hyaluronan and the hyaluronan-binding proteoglycans neurocan, aggrecan, and versican by neural stem cells and neural cells derived from embryonic stem cells. Brain Res 1327: 6-15.
  36. Patwari P, Cook MN, DiMicco MA, Blake SM, James IE, Kumar S, Cole AA, Lark MW, Grodzinsky AJ. 2003. Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Arthritis Rheum 48: 1292-1301.
  37. Lee JH, Fitzgerald JB, Dimicco MA, Grodzinsky AJ. 2005. Mechanical injury of cartilage explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum 52: 2386-2395.
  38. Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J. 1997. Collagenase-3 (matrix metalloprotease 13) is preferentially localized in the deep layer of human arthritic cartilage in situ: in vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 40: 1653-1661.

Cited by

  1. Effect ofHijikia fusiformeextracts on degenerative osteoarthritisin vitroandin vivomodels vol.10, pp.3, 2016,
  2. Effect of Mulberry Extract Complex on Degenerative Arthritis In Vivo Models vol.45, pp.5, 2016,
  3. Selection of the optimal herbal composition of pomegranate concentrated powder from aqueous extracts of and to treat osteoarthritis in rats vol.38, pp.4, 2017,
  4. Anti-osteoarthritic effects of a combination of pomegranate concentrate powder, Eucommiae cortex and Achyranthis radix in rats vol.39, pp.4, 2018,